I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 12 studies | 44% ± 19% | |
| glutamatergic neuron | 7 studies | 40% ± 25% | |
| GABAergic neuron | 6 studies | 43% ± 21% | |
| CD16-negative, CD56-bright natural killer cell, human | 5 studies | 18% ± 2% | |
| CD4-positive, alpha-beta T cell | 5 studies | 21% ± 4% | |
| naive thymus-derived CD4-positive, alpha-beta T cell | 5 studies | 19% ± 2% | |
| oligodendrocyte precursor cell | 5 studies | 33% ± 13% | |
| B cell | 4 studies | 17% ± 2% | |
| T cell | 4 studies | 19% ± 2% | |
| neuron | 4 studies | 30% ± 17% | |
| endothelial cell | 4 studies | 28% ± 1% | |
| plasma cell | 4 studies | 25% ± 7% | |
| epithelial cell | 4 studies | 23% ± 4% | |
| lymphocyte | 4 studies | 23% ± 4% | |
| astrocyte | 4 studies | 33% ± 9% | |
| interneuron | 4 studies | 44% ± 26% | |
| plasmablast | 3 studies | 28% ± 7% | |
| innate lymphoid cell | 3 studies | 21% ± 3% | |
| gamma-delta T cell | 3 studies | 20% ± 3% |
